Home/Replimune/Sushil Patel
SP

Sushil Patel

Chief Executive Officer

Replimune

Therapeutic Areas

Replimune Pipeline

DrugIndicationPhase
RP1Advanced MelanomaPhase 2/3
RP2Metastatic Uveal MelanomaPhase 2/3